Reduced levels of miR-34a were also observed in human gliomas, which correlated with increased expression of the target oncogenes c-Met, Notch-1/2 and cyclin-dependent kinase 6 (CDK6) in glioma and stem cells [54]. This evidence concerns the gene CDK6 and central nervous system cancer.